International Journal of Clinical Pharmacy

, Volume 36, Issue 1, pp 20–25 | Cite as

Interventions aimed at improving performance on medication adherence metrics

  • Brandy McGinnisEmail author
  • Yardlee Kauffman
  • Kari L. Olson
  • Daniel M. Witt
  • Marsha A. Raebel


Background medication adherence is one determining factor of treatment success. Poor medication adherence mitigates optimum clinical benefits and increases total health care costs. Current evidence suggests that for population-based adherence interventions to be effective, a multidisciplinary, multifactorial approach that can be tailored for each individual should be adopted. In the United States, national organizations such as the National Committee for Quality Assurance and the Centers for Medicare and Medicaid Services include medication adherence as a metric of health care system performance Aim of the Commentary This article provides an overview of efforts at Kaiser Permanente Colorado to impact medication adherence-related metrics. Described interventions are supported by electronic data gathering processes with an emphasis on the role of pharmacists.


Managed care program Medicare Medication adherence Pharmacists 



This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Conflicts of interest

All authors are employed by KPCO and declare no other conflicts of interest.


  1. 1.
    World Health Organization [Internet]. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization; c 2003 [cited 2013 May 22]. Available from:
  2. 2.
    Cramer J, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60(7):657–65.PubMedGoogle Scholar
  4. 4.
    Crowley MJ, Grubber JM, Olsen MK, Bosworth HB. Factors associated with non-adherence to three hypertension self-management behaviors: preliminary data for a new instrument. J Gen Intern Med. 2012;28(1):99–106.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Yood RA, Mazor KM, Andrade SE, Emani S, Chan W, Kahler KH. Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs. J Gen Intern Med. 2008;23(11):1815–21.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Shrank WH, Choudhry NK, Fischer MA, Avorn J, Powell M, Schneeweiss S, et al. The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med. 2010;153(10):640–4.CrossRefGoogle Scholar
  7. 7.
    Solomon DH, Brookhart MA, Tsao P, Sundaresan D, Andrade SE, Mazor K, et al. Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction rule. Osteoporos Int. 2011;22(6):1734–43.CrossRefGoogle Scholar
  8. 8.
    Krousel-Wood M, Islam T, Muntner P, Holt E, Joyce C, Morisky DE, et al. Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. Ann Behav Med. 2010;40(3):248–57.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Zeller A, Taegtmeyer A, Martina B, Battegay E, Tschudi P. Physicians’ ability to predict patients’ adherence to antihypertensive medication in primary care. Hypertens Res. 2008;31(9):1765–71.PubMedCrossRefGoogle Scholar
  10. 10.
    McHorney CA. The adherence estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 2009;25(1):215–38.PubMedCrossRefGoogle Scholar
  11. 11.
    Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between non-adherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008;61(3):282–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15:90–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Raebel MA, Schmittdiel J, Karter AJ, Konieczny JF, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51(8 Suppl 3):S11–21.PubMedCrossRefGoogle Scholar
  14. 14.
    PQA Pharmacy Quality Alliance [Internet]. Virginia: Pharmacy Quality Alliance; [cited 2013 May 22]. Available from:
  15. 15.
    Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock S, Wines RCM, et al. Medication adherence interventions: comparative effectiveness. Closing the quality gap: revisiting the state of the science. Evidence Report No. 208. (Prepared by RTI International–University of North Carolina Evidence-based Practice Center under Contract No. 290-2007-10056-I.) AHRQ Publication No. 12-E010-EF. Rockville, MD: Agency for Healthcare Research and Quality. September 2012.
  16. 16.
    Steiner JF, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C, et al. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes. 2009;2(5):451–7.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, Liu J, et al. Patient, physician, and payment predictors of statin adherence. Med Care. 2010;48(3):196–202.PubMedCrossRefGoogle Scholar
  18. 18.
    Raebel MA, Ellis JL, Carroll NM, Bayliss EA, McGinnis B, Schroeder EB, et al. Characteristics of patients with primary nonadherence to medications for hypertension, diabetes, and lipid disorders. J Gen Intern Med. 2012;27(1):57–64.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–30.PubMedCrossRefGoogle Scholar
  20. 20.
    Bosworth HB, Granger BB, Mendys P, Brindis R, Burkholder R, Czajkowski SM, et al. Medication adherence: a call for action. Am Heart J. 2011;162(3):412–24.PubMedCrossRefGoogle Scholar
  21. 21.
    Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–41.PubMedCrossRefGoogle Scholar
  22. 22.
    Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.PubMedCrossRefGoogle Scholar
  23. 23.
    Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care. 2005;43(6):517–20.PubMedCrossRefGoogle Scholar
  24. 24.
    Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y, Edelstein S, et al. Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program. Diab Care. 2006;29(9):1997–2002.CrossRefGoogle Scholar
  25. 25.
    Wu JR, Moser DK, DeJong MJ, Rayens MK, Chung ML, Riegel B, et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J. 2009;157(2):285–91.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    McGinnis BD, Olson KL, Delate TMA, Stolcpart RS. Statin adherence and mortality in patients enrolled in a secondary prevention program. Am J Manag Care. 2009;15(10):689–95.PubMedGoogle Scholar
  27. 27.
    Ho PM, Magid DJ, Shetterly SM, Olson KL, Peterson PN, Masoudi FA, et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med. 2008;168(3):271–6.PubMedCrossRefGoogle Scholar
  28. 28.
    McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care. 1994;32(3):214–26.PubMedCrossRefGoogle Scholar
  29. 29.
    Osterburg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.CrossRefGoogle Scholar
  30. 30.
    Cutler DM, Everett W. Thinking outside the pillbox—medication adherence as a priority for health care reform. N Engl J Med. 2010;362(17):1553–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Roebuck MC, Liberman JN, Gemmill-Toyama M. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. 2011;30(1):91–9.CrossRefGoogle Scholar
  32. 32.
    NCQA [Internet]. [Washington DC]: National Committee for Quality Assurance; [cited 2013 June 6]. Available from:
  33. 33.
    Centers for Medicare and Medicaid Services [Internet]. Baltimore: Centers for Medicare and Medicaid Services; [cited 2013 May 22]. Available from:
  34. 34.
    Helling DK, Nelson K, Ramirez JE, Humphries TL. Kaiser Permanente Colorado Region Pharmacy Department: innovative leader in pharmacy practice. J Am Pharm Assoc. 2006;46(1):67–76.CrossRefGoogle Scholar
  35. 35.
    Steiner JF. Rethinking adherence. Ann Intern Med. 2012;157(8):580–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Touchette DR, Shapiro NL. Medication compliance, adherence, and persistence: current status of behavioral and education interventions to improve outcomes. J Manag Care Pharm. 2008;14(6):S2–10.Google Scholar
  37. 37.
    Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004;2:CD004804.PubMedGoogle Scholar
  38. 38.
    Schedlbauer A, Davies P, Fahey T. Intervention to improve patients’ drug-taking behavior to lipid lowering drugs. Cochrane Database Syst Rev. 2010;3:004371.Google Scholar
  39. 39.
    Taitel M, Jiang J, Rudkin K, Ewing S, Duncan I. The impact of pharmacist face-to-face counseling to improve medication adherence among patients initiating statin therapy. Patient Prefer Adherence. 2012;6:323–9.PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Vervolet M, Linn AJ, Van Weert JCM, de Bakker DH, Bouvy ML, Van Djk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2011;19(5):696–704.CrossRefGoogle Scholar
  41. 41.
    Granger BB, Bosworth HB. Medication adherence: emerging use of technology. Curr Opin Cardiol. 2011;26(4):279–87.PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Oyekan E, Nimalasuriya A, Martin J, Scott R, Dudl RJ, Green K. The B-SMART appropriate medication-use process: a guide for clinicians to help patients—part 1: barriers, solutions, and motivation. Perm J. 2009;13(1):62–9.PubMedCentralPubMedGoogle Scholar
  43. 43.
    Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–95.PubMedCrossRefGoogle Scholar
  44. 44.
    Topinková E, Baeyens JP, Michel JP, Lang PO. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging. 2012;29(6):477–94.PubMedCrossRefGoogle Scholar
  45. 45.
    Pellegrino AN, Martin MT, Tilton JJ, Touchette DR. Medication therapy management: definitions and outcomes. Drugs. 2009;69(4):393–406.PubMedCrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2013

Authors and Affiliations

  • Brandy McGinnis
    • 1
    Email author
  • Yardlee Kauffman
    • 1
  • Kari L. Olson
    • 1
  • Daniel M. Witt
    • 1
  • Marsha A. Raebel
    • 2
  1. 1.Kaiser Permanante ColoradoUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesAuroraUSA
  2. 2.Kaiser Permanente ColoradoUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesDenverUSA

Personalised recommendations